The free radical scavenger, edaravone, ameliorates delayed neuropsychological sequelae after acute carbon monoxide poisoning in rabbits

Undersea and Hyperbaric Medicine

Volumn 40, Issue 3, 2013, Pages 223-229

  Wang, Qingsong ^a   Guan, Yeming ^a   Liu, Xuechun ^a   Liu, Hongjuan ^a   Wang, Jing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CHOLINE; CREATINE; DRUG DERIVATIVE; LACTIC ACID; MALONALDEHYDE; N ACETYLASPARTIC ACID; N-ACETYLASPARTATE; PHENAZONE; PHENYLMETHYLPYRAZOLONE; SCAVENGER; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE;

ANIMAL; APOPTOSIS; ARTICLE; BLOOD; CARBON MONOXIDE INTOXICATION; DRUG EFFECT; HIPPOCAMPUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; NERVE CELL; NICK END LABELING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; RABBIT; RANDOMIZATION;

ANIMALS; ANTIPYRINE; APOPTOSIS; ASPARTIC ACID; CARBON MONOXIDE POISONING; CHOLINE; CREATINE; FREE RADICAL SCAVENGERS; HIPPOCAMPUS; IN SITU NICK-END LABELING; INFUSIONS, INTRAVENOUS; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MALONDIALDEHYDE; NEURONS; RABBITS; RANDOM ALLOCATION; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE;

EID: 84877994726     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Weaver LK. Clinical practice. Carbon monoxide poisoning. N Engl J Med 2009; 360:1217-25.
2. Hampson NB, Weaver LK Carbon monoxide poisoning: a new incidence for an old disease. Undersea Hyperb Med 2007; 34:163-8.
3. Stoller KP. Hyperbaric oxygen and carbon monoxide poisoning: a critical review. Neurol Res 2007; 29:146-55 (Pubitemid 46685268)
4. Weaver LK, Valentine KJ, Hopkins RO Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen. Am J Respir Crit Care Med 2007; 176:491-7. (Pubitemid 47358103)
5. Thom SR. Carbon monoxide pathophysiology and treatment. In: Neuman TS, Thom SR, eds. Physiology and medicine of hyperbaric oxygen therapy. Philadelphia: Saunders Elsevier, 2008, 321-47.
6. Mannaioni PF, Vannacci A, Masini E. Carbon monoxide: the bad and the good side of the coin, from neuronal death to anti-inflammatory activity. Inflamm Res 2006; 55:261-73. (Pubitemid 44359129)
7. Zhang X, Shan P, Otterbein L.E., Alam J., Flavell RA, Davis RJ, Choi AM, Lee PJ Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogenactivated protein kinase pathway and involves caspase 3. J Biol Chem 2003; 278:1248-58. (Pubitemid 36790808)
8. Taillé C, Almolki A, Benhamed M, et al. Heme oxyge-nase inhibits human air way smooth muscle proliferation via a bilirubindependent modulation of ERK1/2 phosphorylation. J Biol Chem 2003; 278:27160-8. (Pubitemid 36876872)
9. Suliman HB, Carraway MS, Tatro L.G., Piantadosi CA A new activating role for CO in cardiac mitochondrial biogenesis. J Cell Sci 2007; 120:299-308.
10. Alonso JR, Cardellach F, López S, Casademont J., Miró O. Carbon monoxide specifically inhibits cytochrome c oxidase of human mitochondrial respiratory chain. Pharmacol Toxicol 2003; 93:142-6. (Pubitemid 37108543)
11. Nakase T, Yoshioka S, Suzuki A. Free radical scavenger, edaravone, reduces thelesion size of lacunar infarction in human brain ischemic stroke. BMC Neurology 2011; 11:39
12. Piantadosi CA, Zhang J, Levin E.D., Folz RJ, Schmechel DE Apoptosis and delayed neuronal damage after carbon monoxide poisoning in the rat. Exp Neurol 1997; 147:103-14. (Pubitemid 27402447)
13. Rodkey FL, Hill TA, Pitts L.L., Robertson RF Spectropho-tometric measurement of carboxyhemoglobin and methemo-globin in blood. Clin Chem. 1979:25:1388-93. (Pubitemid 9247020)
14. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34:497-500.
15. Wasowicz W, Neve J, Peretz A. Optimized steps in fluo-rometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993; 39: 2522-2526. (Pubitemid 24008241)
16. Kenshi T, Hironaka I, Masaki H., Hitoshi M, Masatoyo N, Tsutomu N. Serial assessments of delayed encephalopathy after carbon monoxide poisoning using magnetic resonance spectroscopy and diffusion tensor imaging 3.0T system. Eur Neurol 2008; 59:55-61.
17. Ostrowski RP, Graupner G, Titova E., Zhang J, Chiu J, Dach N., Corleone D, Tang J, and Zhang JH. The hyperbaric oxygen preconditioning-induced brain protectionis mediated by a reduction of early apoptosis after transient globalcerebral ischemia. Neurobiol Dis. 2008; 29: 1-13. (Pubitemid 350180478)
18. Hirotsugu K, Hirohiko K, Tetsuhito M. Carbon monoxide poisoning: Two case of assessment by magnetization transfer ratios and 1H-MRS for brain damage. Radiation Medicine 2004; 22:190-194.
19. Matthews PM, Francis G, Antel J., Arnold DL Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 1991, 41:1251-1256.
20. Miller DH, Austin SJ, Connelly A, Youl B.D., Gadian DG, McDonald WI Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis. Lancet 1991; 337:58-59.
21. Kruse B, Barker PB, van Zijl PC, Duyn JH, Moonen CT, Moser HW Multislice proton magnetic resonance spectro-scopic imaging in X-linked adrenoleukodystrophy. Ann Neurol 1994; 36:595-608. (Pubitemid 24309371)
22. Handa Y, Kaneko M, Matuda T., Kobayashi H, Kubota T. In-vivo proton magnetic resonance spectroscopy for metabolic changes in brain during chronic cerebral vasospasm in primates. Neurosurgery 1997; 40:773-780.
23. Kondziella D, Danielsen ER, Hansen K, Thomsen C., Jansen EC, Arlien-Soeborg P. 1H MR spectroscopy of gray and white matter in carbon monoxide poisoning. J Neurol 2009; 256:970-979
24. Watanabe T, Tahara M, Todo S. The novel antioxidant edaravone: from bench to bedside. Cardiovasc Ther 2008; 26:101-114. (Pubitemid 351952827)
25. Yoshida H, Yanai H, Namiki Y., Fukatsu-Sasaki K, Furutani N, Tada N. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 2006; 12:9-20. (Pubitemid 44133577)
26. Lapchak PA. A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? Expert Opin Pharmacother. 2010; 11:1753-1763
27. Zhang N, Komine-Kobayashi M, Tanaka R., Liu M, Mizuno Y, Urabe T. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 2005; 36:2220-2225. (Pubitemid 41429250)
28. Lee BJ, Egi Y, van Leyen K, Lo EH, Arai K. Edaravone, a free radical scavenger, protects components of the neuro-vascular unit against oxidative stress in vitro. Brain Res 2010; 1307:22-27.
29. Xi H, Akishita M, Nagai K., Yu W, Hasegawa H, Eto M., Kozaki K, Toba K. Potent free radical scavenger, edaravone, suppresses oxidative stressinduced endothelial damage and early atherosclerosis. Atherosclerosis 2007; 191:281-289. (Pubitemid 46400711)
30. Banno M, Mizuno T, Kato H., Zhang G, Kawanokuchi J, Wang J., Kuno R, Jin S, Takeuchi H, Suzumura A: The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia. Neuropharmacology 2005; 48:283-290. (Pubitemid 40208264)